Global Point-of-Care Testing (POCT) Market Size, Manufacturers, Opportunities and Forecast to 2030
Point-of-care (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.
According to APO Research, The global Point-of-Care Testing (POCT) market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Point-of-Care Testing (POCT) main players are Roche, Abbott, Johnson & Johnson, etc. Global top three manufacturers hold a share over 45%. North America is the largest market, with a share nearly 40%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Point-of-Care Testing (POCT), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Point-of-Care Testing (POCT).
The Point-of-Care Testing (POCT) market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Point-of-Care Testing (POCT) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Point-of-Care Testing (POCT) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Point-of-Care Testing (POCT) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Point-of-Care Testing (POCT).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Point-of-Care Testing (POCT) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Point-of-Care Testing (POCT) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
According to APO Research, The global Point-of-Care Testing (POCT) market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Point-of-Care Testing (POCT) main players are Roche, Abbott, Johnson & Johnson, etc. Global top three manufacturers hold a share over 45%. North America is the largest market, with a share nearly 40%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Point-of-Care Testing (POCT), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Point-of-Care Testing (POCT).
The Point-of-Care Testing (POCT) market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Point-of-Care Testing (POCT) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Roche
- Abbott
- Johnson & Johnson
- Siemens Healthcare
- Danaher
- Ascensia
- Bio-Rad Laboratories
- BioMerieux
- ARKRAY
- Nova Biomedical
- Trividia Health
- Quidel
- Accriva
- OraSure Technologies
- Helena Laboratories
- A. Menarini Diagnostics
- Abaxis (Zoetis)
- Ortho Clinical Diagnostics
- Phamatech
- Chembio Diagnostics
- Trinity Biotech
- ELITech Group
- Response Biomedical
- Princeton BioMeditech
- Alfa Wassermann
- Blood Glucose Testing
- Infectious Diseases Testing
- Cardiac Markers Testing
- Coagulation Testing
- Pregnancy and Fertility Testing
- Blood Gas/Electrolytes Testing
- Urinalysis Testing
- Clinics
- Hospitals
- Laboratory
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Point-of-Care Testing (POCT) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Point-of-Care Testing (POCT) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Point-of-Care Testing (POCT).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Point-of-Care Testing (POCT) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Point-of-Care Testing (POCT) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Point-of-Care Testing (POCT) Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Point-of-Care Testing (POCT) Sales Estimates and Forecasts (2019-2030)
1.3 Point-of-Care Testing (POCT) Market by Type
1.3.1 Blood Glucose Testing
1.3.2 Infectious Diseases Testing
1.3.3 Cardiac Markers Testing
1.3.4 Coagulation Testing
1.3.5 Pregnancy and Fertility Testing
1.3.6 Blood Gas/Electrolytes Testing
1.3.7 Urinalysis Testing
1.4 Global Point-of-Care Testing (POCT) Market Size by Type
1.4.1 Global Point-of-Care Testing (POCT) Market Size Overview by Type (2019-2030)
1.4.2 Global Point-of-Care Testing (POCT) Historic Market Size Review by Type (2019-2024)
1.4.3 Global Point-of-Care Testing (POCT) Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Point-of-Care Testing (POCT) Sales Breakdown by Type (2019-2024)
1.5.2 Europe Point-of-Care Testing (POCT) Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Point-of-Care Testing (POCT) Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Point-of-Care Testing (POCT) Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Point-of-Care Testing (POCT) Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Point-of-Care Testing (POCT) Industry Trends
2.2 Point-of-Care Testing (POCT) Industry Drivers
2.3 Point-of-Care Testing (POCT) Industry Opportunities and Challenges
2.4 Point-of-Care Testing (POCT) Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Point-of-Care Testing (POCT) Revenue (2019-2024)
3.2 Global Top Players by Point-of-Care Testing (POCT) Sales (2019-2024)
3.3 Global Top Players by Point-of-Care Testing (POCT) Price (2019-2024)
3.4 Global Point-of-Care Testing (POCT) Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Point-of-Care Testing (POCT) Key Company Manufacturing Sites & Headquarters
3.6 Global Point-of-Care Testing (POCT) Company, Product Type & Application
3.7 Global Point-of-Care Testing (POCT) Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Point-of-Care Testing (POCT) Market CR5 and HHI
3.8.2 Global Top 5 and 10 Point-of-Care Testing (POCT) Players Market Share by Revenue in 2023
3.8.3 2023 Point-of-Care Testing (POCT) Tier 1, Tier 2, and Tier
4 POINT-OF-CARE TESTING (POCT) REGIONAL STATUS AND OUTLOOK
4.1 Global Point-of-Care Testing (POCT) Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Point-of-Care Testing (POCT) Historic Market Size by Region
4.2.1 Global Point-of-Care Testing (POCT) Sales in Volume by Region (2019-2024)
4.2.2 Global Point-of-Care Testing (POCT) Sales in Value by Region (2019-2024)
4.2.3 Global Point-of-Care Testing (POCT) Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Point-of-Care Testing (POCT) Forecasted Market Size by Region
4.3.1 Global Point-of-Care Testing (POCT) Sales in Volume by Region (2025-2030)
4.3.2 Global Point-of-Care Testing (POCT) Sales in Value by Region (2025-2030)
4.3.3 Global Point-of-Care Testing (POCT) Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 POINT-OF-CARE TESTING (POCT) BY APPLICATION
5.1 Point-of-Care Testing (POCT) Market by Application
5.1.1 Clinics
5.1.2 Hospitals
5.1.3 Laboratory
5.1.4 Others
5.2 Global Point-of-Care Testing (POCT) Market Size by Application
5.2.1 Global Point-of-Care Testing (POCT) Market Size Overview by Application (2019-2030)
5.2.2 Global Point-of-Care Testing (POCT) Historic Market Size Review by Application (2019-2024)
5.2.3 Global Point-of-Care Testing (POCT) Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Point-of-Care Testing (POCT) Sales Breakdown by Application (2019-2024)
5.3.2 Europe Point-of-Care Testing (POCT) Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Point-of-Care Testing (POCT) Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Point-of-Care Testing (POCT) Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Point-of-Care Testing (POCT) Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 Roche
6.1.1 Roche Comapny Information
6.1.2 Roche Business Overview
6.1.3 Roche Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Roche Point-of-Care Testing (POCT) Product Portfolio
6.1.5 Roche Recent Developments
6.2 Abbott
6.2.1 Abbott Comapny Information
6.2.2 Abbott Business Overview
6.2.3 Abbott Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Abbott Point-of-Care Testing (POCT) Product Portfolio
6.2.5 Abbott Recent Developments
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Comapny Information
6.3.2 Johnson & Johnson Business Overview
6.3.3 Johnson & Johnson Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Johnson & Johnson Point-of-Care Testing (POCT) Product Portfolio
6.3.5 Johnson & Johnson Recent Developments
6.4 Siemens Healthcare
6.4.1 Siemens Healthcare Comapny Information
6.4.2 Siemens Healthcare Business Overview
6.4.3 Siemens Healthcare Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Siemens Healthcare Point-of-Care Testing (POCT) Product Portfolio
6.4.5 Siemens Healthcare Recent Developments
6.5 Danaher
6.5.1 Danaher Comapny Information
6.5.2 Danaher Business Overview
6.5.3 Danaher Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Danaher Point-of-Care Testing (POCT) Product Portfolio
6.5.5 Danaher Recent Developments
6.6 Ascensia
6.6.1 Ascensia Comapny Information
6.6.2 Ascensia Business Overview
6.6.3 Ascensia Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Ascensia Point-of-Care Testing (POCT) Product Portfolio
6.6.5 Ascensia Recent Developments
6.7 Bio-Rad Laboratories
6.7.1 Bio-Rad Laboratories Comapny Information
6.7.2 Bio-Rad Laboratories Business Overview
6.7.3 Bio-Rad Laboratories Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Bio-Rad Laboratories Point-of-Care Testing (POCT) Product Portfolio
6.7.5 Bio-Rad Laboratories Recent Developments
6.8 BioMerieux
6.8.1 BioMerieux Comapny Information
6.8.2 BioMerieux Business Overview
6.8.3 BioMerieux Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 BioMerieux Point-of-Care Testing (POCT) Product Portfolio
6.8.5 BioMerieux Recent Developments
6.9 ARKRAY
6.9.1 ARKRAY Comapny Information
6.9.2 ARKRAY Business Overview
6.9.3 ARKRAY Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 ARKRAY Point-of-Care Testing (POCT) Product Portfolio
6.9.5 ARKRAY Recent Developments
6.10 Nova Biomedical
6.10.1 Nova Biomedical Comapny Information
6.10.2 Nova Biomedical Business Overview
6.10.3 Nova Biomedical Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Nova Biomedical Point-of-Care Testing (POCT) Product Portfolio
6.10.5 Nova Biomedical Recent Developments
6.11 Trividia Health
6.11.1 Trividia Health Comapny Information
6.11.2 Trividia Health Business Overview
6.11.3 Trividia Health Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Trividia Health Point-of-Care Testing (POCT) Product Portfolio
6.11.5 Trividia Health Recent Developments
6.12 Quidel
6.12.1 Quidel Comapny Information
6.12.2 Quidel Business Overview
6.12.3 Quidel Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Quidel Point-of-Care Testing (POCT) Product Portfolio
6.12.5 Quidel Recent Developments
6.13 Accriva
6.13.1 Accriva Comapny Information
6.13.2 Accriva Business Overview
6.13.3 Accriva Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Accriva Point-of-Care Testing (POCT) Product Portfolio
6.13.5 Accriva Recent Developments
6.14 OraSure Technologies
6.14.1 OraSure Technologies Comapny Information
6.14.2 OraSure Technologies Business Overview
6.14.3 OraSure Technologies Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.14.4 OraSure Technologies Point-of-Care Testing (POCT) Product Portfolio
6.14.5 OraSure Technologies Recent Developments
6.15 Helena Laboratories
6.15.1 Helena Laboratories Comapny Information
6.15.2 Helena Laboratories Business Overview
6.15.3 Helena Laboratories Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Helena Laboratories Point-of-Care Testing (POCT) Product Portfolio
6.15.5 Helena Laboratories Recent Developments
6.16 A. Menarini Diagnostics
6.16.1 A. Menarini Diagnostics Comapny Information
6.16.2 A. Menarini Diagnostics Business Overview
6.16.3 A. Menarini Diagnostics Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.16.4 A. Menarini Diagnostics Point-of-Care Testing (POCT) Product Portfolio
6.16.5 A. Menarini Diagnostics Recent Developments
6.17 Abaxis (Zoetis)
6.17.1 Abaxis (Zoetis) Comapny Information
6.17.2 Abaxis (Zoetis) Business Overview
6.17.3 Abaxis (Zoetis) Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Abaxis (Zoetis) Point-of-Care Testing (POCT) Product Portfolio
6.17.5 Abaxis (Zoetis) Recent Developments
6.18 Ortho Clinical Diagnostics
6.18.1 Ortho Clinical Diagnostics Comapny Information
6.18.2 Ortho Clinical Diagnostics Business Overview
6.18.3 Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Product Portfolio
6.18.5 Ortho Clinical Diagnostics Recent Developments
6.19 Phamatech
6.19.1 Phamatech Comapny Information
6.19.2 Phamatech Business Overview
6.19.3 Phamatech Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Phamatech Point-of-Care Testing (POCT) Product Portfolio
6.19.5 Phamatech Recent Developments
6.20 Chembio Diagnostics
6.20.1 Chembio Diagnostics Comapny Information
6.20.2 Chembio Diagnostics Business Overview
6.20.3 Chembio Diagnostics Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Chembio Diagnostics Point-of-Care Testing (POCT) Product Portfolio
6.20.5 Chembio Diagnostics Recent Developments
6.21 Trinity Biotech
6.21.1 Trinity Biotech Comapny Information
6.21.2 Trinity Biotech Business Overview
6.21.3 Trinity Biotech Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Trinity Biotech Point-of-Care Testing (POCT) Product Portfolio
6.21.5 Trinity Biotech Recent Developments
6.22 ELITech Group
6.22.1 ELITech Group Comapny Information
6.22.2 ELITech Group Business Overview
6.22.3 ELITech Group Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.22.4 ELITech Group Point-of-Care Testing (POCT) Product Portfolio
6.22.5 ELITech Group Recent Developments
6.23 Response Biomedical
6.23.1 Response Biomedical Comapny Information
6.23.2 Response Biomedical Business Overview
6.23.3 Response Biomedical Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Response Biomedical Point-of-Care Testing (POCT) Product Portfolio
6.23.5 Response Biomedical Recent Developments
6.24 Princeton BioMeditech
6.24.1 Princeton BioMeditech Comapny Information
6.24.2 Princeton BioMeditech Business Overview
6.24.3 Princeton BioMeditech Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.24.4 Princeton BioMeditech Point-of-Care Testing (POCT) Product Portfolio
6.24.5 Princeton BioMeditech Recent Developments
6.25 Alfa Wassermann
6.25.1 Alfa Wassermann Comapny Information
6.25.2 Alfa Wassermann Business Overview
6.25.3 Alfa Wassermann Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.25.4 Alfa Wassermann Point-of-Care Testing (POCT) Product Portfolio
6.25.5 Alfa Wassermann Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Point-of-Care Testing (POCT) Sales by Country
7.1.1 North America Point-of-Care Testing (POCT) Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Point-of-Care Testing (POCT) Sales by Country (2019-2024)
7.1.3 North America Point-of-Care Testing (POCT) Sales Forecast by Country (2025-2030)
7.2 North America Point-of-Care Testing (POCT) Market Size by Country
7.2.1 North America Point-of-Care Testing (POCT) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Point-of-Care Testing (POCT) Market Size by Country (2019-2024)
7.2.3 North America Point-of-Care Testing (POCT) Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Point-of-Care Testing (POCT) Sales by Country
8.1.1 Europe Point-of-Care Testing (POCT) Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Point-of-Care Testing (POCT) Sales by Country (2019-2024)
8.1.3 Europe Point-of-Care Testing (POCT) Sales Forecast by Country (2025-2030)
8.2 Europe Point-of-Care Testing (POCT) Market Size by Country
8.2.1 Europe Point-of-Care Testing (POCT) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Point-of-Care Testing (POCT) Market Size by Country (2019-2024)
8.2.3 Europe Point-of-Care Testing (POCT) Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Point-of-Care Testing (POCT) Sales by Country
9.1.1 Asia-Pacific Point-of-Care Testing (POCT) Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Point-of-Care Testing (POCT) Sales by Country (2019-2024)
9.1.3 Asia-Pacific Point-of-Care Testing (POCT) Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Point-of-Care Testing (POCT) Market Size by Country
9.2.1 Asia-Pacific Point-of-Care Testing (POCT) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Point-of-Care Testing (POCT) Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Point-of-Care Testing (POCT) Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Point-of-Care Testing (POCT) Sales by Country
10.1.1 Latin America Point-of-Care Testing (POCT) Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Point-of-Care Testing (POCT) Sales by Country (2019-2024)
10.1.3 Latin America Point-of-Care Testing (POCT) Sales Forecast by Country (2025-2030)
10.2 Latin America Point-of-Care Testing (POCT) Market Size by Country
10.2.1 Latin America Point-of-Care Testing (POCT) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Point-of-Care Testing (POCT) Market Size by Country (2019-2024)
10.2.3 Latin America Point-of-Care Testing (POCT) Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Point-of-Care Testing (POCT) Sales by Country
11.1.1 Middle East and Africa Point-of-Care Testing (POCT) Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Point-of-Care Testing (POCT) Sales by Country (2019-2024)
11.1.3 Middle East and Africa Point-of-Care Testing (POCT) Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Point-of-Care Testing (POCT) Market Size by Country
11.2.1 Middle East and Africa Point-of-Care Testing (POCT) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Point-of-Care Testing (POCT) Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Point-of-Care Testing (POCT) Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Point-of-Care Testing (POCT) Value Chain Analysis
12.1.1 Point-of-Care Testing (POCT) Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Point-of-Care Testing (POCT) Production Mode & Process
12.2 Point-of-Care Testing (POCT) Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Point-of-Care Testing (POCT) Distributors
12.2.3 Point-of-Care Testing (POCT) Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Point-of-Care Testing (POCT) Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Point-of-Care Testing (POCT) Sales Estimates and Forecasts (2019-2030)
1.3 Point-of-Care Testing (POCT) Market by Type
1.3.1 Blood Glucose Testing
1.3.2 Infectious Diseases Testing
1.3.3 Cardiac Markers Testing
1.3.4 Coagulation Testing
1.3.5 Pregnancy and Fertility Testing
1.3.6 Blood Gas/Electrolytes Testing
1.3.7 Urinalysis Testing
1.4 Global Point-of-Care Testing (POCT) Market Size by Type
1.4.1 Global Point-of-Care Testing (POCT) Market Size Overview by Type (2019-2030)
1.4.2 Global Point-of-Care Testing (POCT) Historic Market Size Review by Type (2019-2024)
1.4.3 Global Point-of-Care Testing (POCT) Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Point-of-Care Testing (POCT) Sales Breakdown by Type (2019-2024)
1.5.2 Europe Point-of-Care Testing (POCT) Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Point-of-Care Testing (POCT) Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Point-of-Care Testing (POCT) Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Point-of-Care Testing (POCT) Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Point-of-Care Testing (POCT) Industry Trends
2.2 Point-of-Care Testing (POCT) Industry Drivers
2.3 Point-of-Care Testing (POCT) Industry Opportunities and Challenges
2.4 Point-of-Care Testing (POCT) Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Point-of-Care Testing (POCT) Revenue (2019-2024)
3.2 Global Top Players by Point-of-Care Testing (POCT) Sales (2019-2024)
3.3 Global Top Players by Point-of-Care Testing (POCT) Price (2019-2024)
3.4 Global Point-of-Care Testing (POCT) Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Point-of-Care Testing (POCT) Key Company Manufacturing Sites & Headquarters
3.6 Global Point-of-Care Testing (POCT) Company, Product Type & Application
3.7 Global Point-of-Care Testing (POCT) Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Point-of-Care Testing (POCT) Market CR5 and HHI
3.8.2 Global Top 5 and 10 Point-of-Care Testing (POCT) Players Market Share by Revenue in 2023
3.8.3 2023 Point-of-Care Testing (POCT) Tier 1, Tier 2, and Tier
4 POINT-OF-CARE TESTING (POCT) REGIONAL STATUS AND OUTLOOK
4.1 Global Point-of-Care Testing (POCT) Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Point-of-Care Testing (POCT) Historic Market Size by Region
4.2.1 Global Point-of-Care Testing (POCT) Sales in Volume by Region (2019-2024)
4.2.2 Global Point-of-Care Testing (POCT) Sales in Value by Region (2019-2024)
4.2.3 Global Point-of-Care Testing (POCT) Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Point-of-Care Testing (POCT) Forecasted Market Size by Region
4.3.1 Global Point-of-Care Testing (POCT) Sales in Volume by Region (2025-2030)
4.3.2 Global Point-of-Care Testing (POCT) Sales in Value by Region (2025-2030)
4.3.3 Global Point-of-Care Testing (POCT) Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 POINT-OF-CARE TESTING (POCT) BY APPLICATION
5.1 Point-of-Care Testing (POCT) Market by Application
5.1.1 Clinics
5.1.2 Hospitals
5.1.3 Laboratory
5.1.4 Others
5.2 Global Point-of-Care Testing (POCT) Market Size by Application
5.2.1 Global Point-of-Care Testing (POCT) Market Size Overview by Application (2019-2030)
5.2.2 Global Point-of-Care Testing (POCT) Historic Market Size Review by Application (2019-2024)
5.2.3 Global Point-of-Care Testing (POCT) Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Point-of-Care Testing (POCT) Sales Breakdown by Application (2019-2024)
5.3.2 Europe Point-of-Care Testing (POCT) Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Point-of-Care Testing (POCT) Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Point-of-Care Testing (POCT) Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Point-of-Care Testing (POCT) Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 Roche
6.1.1 Roche Comapny Information
6.1.2 Roche Business Overview
6.1.3 Roche Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Roche Point-of-Care Testing (POCT) Product Portfolio
6.1.5 Roche Recent Developments
6.2 Abbott
6.2.1 Abbott Comapny Information
6.2.2 Abbott Business Overview
6.2.3 Abbott Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Abbott Point-of-Care Testing (POCT) Product Portfolio
6.2.5 Abbott Recent Developments
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Comapny Information
6.3.2 Johnson & Johnson Business Overview
6.3.3 Johnson & Johnson Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Johnson & Johnson Point-of-Care Testing (POCT) Product Portfolio
6.3.5 Johnson & Johnson Recent Developments
6.4 Siemens Healthcare
6.4.1 Siemens Healthcare Comapny Information
6.4.2 Siemens Healthcare Business Overview
6.4.3 Siemens Healthcare Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Siemens Healthcare Point-of-Care Testing (POCT) Product Portfolio
6.4.5 Siemens Healthcare Recent Developments
6.5 Danaher
6.5.1 Danaher Comapny Information
6.5.2 Danaher Business Overview
6.5.3 Danaher Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Danaher Point-of-Care Testing (POCT) Product Portfolio
6.5.5 Danaher Recent Developments
6.6 Ascensia
6.6.1 Ascensia Comapny Information
6.6.2 Ascensia Business Overview
6.6.3 Ascensia Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Ascensia Point-of-Care Testing (POCT) Product Portfolio
6.6.5 Ascensia Recent Developments
6.7 Bio-Rad Laboratories
6.7.1 Bio-Rad Laboratories Comapny Information
6.7.2 Bio-Rad Laboratories Business Overview
6.7.3 Bio-Rad Laboratories Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Bio-Rad Laboratories Point-of-Care Testing (POCT) Product Portfolio
6.7.5 Bio-Rad Laboratories Recent Developments
6.8 BioMerieux
6.8.1 BioMerieux Comapny Information
6.8.2 BioMerieux Business Overview
6.8.3 BioMerieux Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 BioMerieux Point-of-Care Testing (POCT) Product Portfolio
6.8.5 BioMerieux Recent Developments
6.9 ARKRAY
6.9.1 ARKRAY Comapny Information
6.9.2 ARKRAY Business Overview
6.9.3 ARKRAY Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 ARKRAY Point-of-Care Testing (POCT) Product Portfolio
6.9.5 ARKRAY Recent Developments
6.10 Nova Biomedical
6.10.1 Nova Biomedical Comapny Information
6.10.2 Nova Biomedical Business Overview
6.10.3 Nova Biomedical Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Nova Biomedical Point-of-Care Testing (POCT) Product Portfolio
6.10.5 Nova Biomedical Recent Developments
6.11 Trividia Health
6.11.1 Trividia Health Comapny Information
6.11.2 Trividia Health Business Overview
6.11.3 Trividia Health Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Trividia Health Point-of-Care Testing (POCT) Product Portfolio
6.11.5 Trividia Health Recent Developments
6.12 Quidel
6.12.1 Quidel Comapny Information
6.12.2 Quidel Business Overview
6.12.3 Quidel Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Quidel Point-of-Care Testing (POCT) Product Portfolio
6.12.5 Quidel Recent Developments
6.13 Accriva
6.13.1 Accriva Comapny Information
6.13.2 Accriva Business Overview
6.13.3 Accriva Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Accriva Point-of-Care Testing (POCT) Product Portfolio
6.13.5 Accriva Recent Developments
6.14 OraSure Technologies
6.14.1 OraSure Technologies Comapny Information
6.14.2 OraSure Technologies Business Overview
6.14.3 OraSure Technologies Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.14.4 OraSure Technologies Point-of-Care Testing (POCT) Product Portfolio
6.14.5 OraSure Technologies Recent Developments
6.15 Helena Laboratories
6.15.1 Helena Laboratories Comapny Information
6.15.2 Helena Laboratories Business Overview
6.15.3 Helena Laboratories Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Helena Laboratories Point-of-Care Testing (POCT) Product Portfolio
6.15.5 Helena Laboratories Recent Developments
6.16 A. Menarini Diagnostics
6.16.1 A. Menarini Diagnostics Comapny Information
6.16.2 A. Menarini Diagnostics Business Overview
6.16.3 A. Menarini Diagnostics Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.16.4 A. Menarini Diagnostics Point-of-Care Testing (POCT) Product Portfolio
6.16.5 A. Menarini Diagnostics Recent Developments
6.17 Abaxis (Zoetis)
6.17.1 Abaxis (Zoetis) Comapny Information
6.17.2 Abaxis (Zoetis) Business Overview
6.17.3 Abaxis (Zoetis) Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Abaxis (Zoetis) Point-of-Care Testing (POCT) Product Portfolio
6.17.5 Abaxis (Zoetis) Recent Developments
6.18 Ortho Clinical Diagnostics
6.18.1 Ortho Clinical Diagnostics Comapny Information
6.18.2 Ortho Clinical Diagnostics Business Overview
6.18.3 Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Product Portfolio
6.18.5 Ortho Clinical Diagnostics Recent Developments
6.19 Phamatech
6.19.1 Phamatech Comapny Information
6.19.2 Phamatech Business Overview
6.19.3 Phamatech Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Phamatech Point-of-Care Testing (POCT) Product Portfolio
6.19.5 Phamatech Recent Developments
6.20 Chembio Diagnostics
6.20.1 Chembio Diagnostics Comapny Information
6.20.2 Chembio Diagnostics Business Overview
6.20.3 Chembio Diagnostics Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Chembio Diagnostics Point-of-Care Testing (POCT) Product Portfolio
6.20.5 Chembio Diagnostics Recent Developments
6.21 Trinity Biotech
6.21.1 Trinity Biotech Comapny Information
6.21.2 Trinity Biotech Business Overview
6.21.3 Trinity Biotech Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Trinity Biotech Point-of-Care Testing (POCT) Product Portfolio
6.21.5 Trinity Biotech Recent Developments
6.22 ELITech Group
6.22.1 ELITech Group Comapny Information
6.22.2 ELITech Group Business Overview
6.22.3 ELITech Group Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.22.4 ELITech Group Point-of-Care Testing (POCT) Product Portfolio
6.22.5 ELITech Group Recent Developments
6.23 Response Biomedical
6.23.1 Response Biomedical Comapny Information
6.23.2 Response Biomedical Business Overview
6.23.3 Response Biomedical Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Response Biomedical Point-of-Care Testing (POCT) Product Portfolio
6.23.5 Response Biomedical Recent Developments
6.24 Princeton BioMeditech
6.24.1 Princeton BioMeditech Comapny Information
6.24.2 Princeton BioMeditech Business Overview
6.24.3 Princeton BioMeditech Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.24.4 Princeton BioMeditech Point-of-Care Testing (POCT) Product Portfolio
6.24.5 Princeton BioMeditech Recent Developments
6.25 Alfa Wassermann
6.25.1 Alfa Wassermann Comapny Information
6.25.2 Alfa Wassermann Business Overview
6.25.3 Alfa Wassermann Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2019-2024)
6.25.4 Alfa Wassermann Point-of-Care Testing (POCT) Product Portfolio
6.25.5 Alfa Wassermann Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Point-of-Care Testing (POCT) Sales by Country
7.1.1 North America Point-of-Care Testing (POCT) Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Point-of-Care Testing (POCT) Sales by Country (2019-2024)
7.1.3 North America Point-of-Care Testing (POCT) Sales Forecast by Country (2025-2030)
7.2 North America Point-of-Care Testing (POCT) Market Size by Country
7.2.1 North America Point-of-Care Testing (POCT) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Point-of-Care Testing (POCT) Market Size by Country (2019-2024)
7.2.3 North America Point-of-Care Testing (POCT) Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Point-of-Care Testing (POCT) Sales by Country
8.1.1 Europe Point-of-Care Testing (POCT) Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Point-of-Care Testing (POCT) Sales by Country (2019-2024)
8.1.3 Europe Point-of-Care Testing (POCT) Sales Forecast by Country (2025-2030)
8.2 Europe Point-of-Care Testing (POCT) Market Size by Country
8.2.1 Europe Point-of-Care Testing (POCT) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Point-of-Care Testing (POCT) Market Size by Country (2019-2024)
8.2.3 Europe Point-of-Care Testing (POCT) Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Point-of-Care Testing (POCT) Sales by Country
9.1.1 Asia-Pacific Point-of-Care Testing (POCT) Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Point-of-Care Testing (POCT) Sales by Country (2019-2024)
9.1.3 Asia-Pacific Point-of-Care Testing (POCT) Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Point-of-Care Testing (POCT) Market Size by Country
9.2.1 Asia-Pacific Point-of-Care Testing (POCT) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Point-of-Care Testing (POCT) Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Point-of-Care Testing (POCT) Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Point-of-Care Testing (POCT) Sales by Country
10.1.1 Latin America Point-of-Care Testing (POCT) Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Point-of-Care Testing (POCT) Sales by Country (2019-2024)
10.1.3 Latin America Point-of-Care Testing (POCT) Sales Forecast by Country (2025-2030)
10.2 Latin America Point-of-Care Testing (POCT) Market Size by Country
10.2.1 Latin America Point-of-Care Testing (POCT) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Point-of-Care Testing (POCT) Market Size by Country (2019-2024)
10.2.3 Latin America Point-of-Care Testing (POCT) Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Point-of-Care Testing (POCT) Sales by Country
11.1.1 Middle East and Africa Point-of-Care Testing (POCT) Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Point-of-Care Testing (POCT) Sales by Country (2019-2024)
11.1.3 Middle East and Africa Point-of-Care Testing (POCT) Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Point-of-Care Testing (POCT) Market Size by Country
11.2.1 Middle East and Africa Point-of-Care Testing (POCT) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Point-of-Care Testing (POCT) Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Point-of-Care Testing (POCT) Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Point-of-Care Testing (POCT) Value Chain Analysis
12.1.1 Point-of-Care Testing (POCT) Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Point-of-Care Testing (POCT) Production Mode & Process
12.2 Point-of-Care Testing (POCT) Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Point-of-Care Testing (POCT) Distributors
12.2.3 Point-of-Care Testing (POCT) Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
